BLSM Conversion Disclosure
Liptak Vincent Paul · SEC Form 4 · Filed Aug 10, 2026
Conversion
Reported value range
Not reported
Liptak Vincent Paul General Counsel
BLSM
Transaction date
Aug 10, 2026
Public filing date
Aug 10, 2026
Filing lag
Filed same day
BLSM daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series B Preferred Stock on Common Stock
- Quantity / price
- 22,687 shares
- SEC ownership
- Indirect
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0002143905-26-000003
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$74.7K
Buys / sales
2 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Blossomhill Therapeutics, Inc. BLSM Current | Conversion | Aug 10, 2026 | Not reported |
| Blossomhill Therapeutics, Inc. BLSM | Buy | Aug 10, 2026 | $35.2K |
| Blossomhill Therapeutics, Inc. BLSM | Conversion | Aug 10, 2026 | Not reported |
| Blossomhill Therapeutics, Inc. BLSM | Buy | Aug 7, 2026 | $39.5K |
| Blossomhill Therapeutics, Inc. BLSM | Award | Aug 6, 2026 | $0 |